Committee Opinion No.682: Microarrays and Next-Generation Sequencing Technology: The Use of Advanced Genetic Diagnostic Tools in Obstetrics and Gynecology

Obstetrics and Gynecology

Volumn 128, Issue 6, 2016, Pages e262-e268

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL FREE WHOLE GENOME DNA SCREENING; CHROMOSOME ANALYSIS; DNA SCREENING; GENETIC SCREENING; GYNECOLOGY; HUMAN; KARYOTYPE; MICROARRAY ANALYSIS; NEXT GENERATION SEQUENCING; OBSTETRICS; PATIENT COUNSELING; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; WHOLE EXOME SEQUENCING; WHOLE GENOME SEQUENCING; CONGENITAL ABNORMALITIES; DNA MICROARRAY; DNA SEQUENCE; EXOME; FEMALE; GENETIC COUNSELING; GENETICS; HUMAN CHROMOSOME; PRACTICE GUIDELINE; PREGNANCY; PROCEDURES;

CHROMOSOMES, HUMAN; CONGENITAL ABNORMALITIES; EXOME; FEMALE; GENETIC COUNSELING; GYNECOLOGY; HUMANS; KARYOTYPE; OBSTETRICS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PRENATAL DIAGNOSIS; SEQUENCE ANALYSIS, DNA;

EID: 84996559058     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000001817     Document Type: Article

References (18)

1. Prenatal diagnostic testing for genetic disorders. Practice Bulletin No. 162. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;127:e108-22. [Obstetrics &Gynecology]
2. Kearney HM, Thorland EC, Brown KK, Quintero-Rivera F, South ST. American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Working Group of the American College of Medical Genetics Laboratory Quality Assurance Committee. Genet Med 2011;13:680-5.
3. Vissers LE, Veltman JA, van Kessel AG, Brunner HG. Identification of disease genes by whole genome CGH arrays. Hum Mol Genet 2005;14 Spec No. 2:R215-23.
4. Reddy UM, Page GP, Saade GR, Silver RM, Thorsten VR, Parker CB, et al. Karyotype versus microarray testing for genetic abnormalities after stillbirth. NICHD Stillbirth Collaborative Research Network. N Engl J Med 2012;367:2185-93.
5. Sahoo T, Dzidic N, Strecker MN, Commander S, Travis MK, Doherty C, et al. Comprehensive genetic analysis of pregnancy loss by chromosomal microarrays: outcomes, benefits, and challenges. Genet Med 2016; DOI: 10.1038/ gim.2016.69.
6. Wapner RJ, Martin CL, Levy B, Ballif BC, Eng CM, Zachary JM, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med 2012;367:2175-84.
7. Shaffer LG, Rosenfeld JA, Dabell MP, Coppinger J, Bandholz AM, Ellison JW, et al. Detection rates of clinically significant genomic alterations by microarray analysis for specific anomalies detected by ultrasound. Prenat Diagn 2012;32:986-95.
8. Brady PD, Delle Chiaie B, Christenhusz G, Dierickx K, Van Den Bogaert K, Menten B, et al. A prospective study of the clinical utility of prenatal chromosomal microarray analysis in fetuses with ultrasound abnormalities and an exploration of a framework for reporting unclassified variants and risk factors. Genet Med 2014;16:469-76. [Full Text]
9. Bernhardt BA, Soucier D, Hanson K, Savage MS, Jackson L, Wapner RJ. Women's experiences receiving abnormal prenatal chromosomal microarray testing results. Genet Med 2013;15:139-45.
10. Riedijk S, Diderich KE, van der Steen SL, Govaerts LC, Joosten M, Knapen MF, et al. The psychological challenges of replacing conventional karyotyping with genomic SNP array analysis in prenatal testing. J Clin Med 2014;3:713-23.
11. Grote L, Myers M, Lovell A, Saal H, Lipscomb Sund K. Variability in laboratory reporting practices for regions of homozygosity indicating parental relatedness as identified by SNP microarray testing. Genet Med 2012;14:971-6.
12. Yang Y, Muzny DM, Reid JG, Bainbridge MN, Willis A, Ward PA, et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N Engl J Med 2013; 369:1502-11.
13. Cukier HN, Dueker ND, Slifer SH, Lee JM, Whitehead PL, Lalanne E, et al. Exome sequencing of extended families with autism reveals genes shared across neurodevelopmental and neuropsychiatric disorders. Mol Autism 2014;5(1):1.
14. Drury S, Williams H, Trump N, Boustred C, GOSGene, Lench N, et al. Exome sequencing for prenatal diagnosis of fetuses with sonographic abnormalities. Prenat Diagn 2015;35:1010-7.
15. Points to consider in the clinical application of genomic sequencing. ACMG Board of Directors. Genet Med 2012; 14:759-61.
16. Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. American College of Medical Genetics and Genomics. Genet Med 2013;15:565-74.
17. Atwal PS, Brennan ML, Cox R, Niaki M, Platt J, Homeyer M, et al. Clinical whole-exome sequencing: are we there yet? Genet Med 2014;16:717-9.
18. Lefkowitz RB, Tynan JA, Liu T, Wu Y, Mazloom AR, Almasri E, et al. Clinical validation of a noninvasive prenatal test for genomewide detection of fetal copy number variants. Am J Obstet Gynecol 2016;215:227.e1-16.